ODRIK Side Effects

6781594-8 | Cardiac Arrest, Hyperkalaemia, Renal Failure Acute
on Jun 09, 2010 Male patient from FRANCE , 66 years of age, was diagnosed with hypertension, atrial fibrillation (What is atrial fibrillation?) and was treated with Odrik (View Usage). Patient experienced the following unwanted or unexpected effects: cardiac arrest (What is cardiac arrest?), hyperkalaemia, renal failure acute. Odrik dosage: . During the same period patient was treated with ZANEXTRA (View Zanextra Review and Zanextra Label ), ZANIDIP (View Zanidip Review and Zanidip Label ), SOTALOL (View Sotalol Review and Sotalol Label ), FLUINDIONE (View Fluindione Review and Fluindione Label ).

6773265-9 | Diabetes Mellitus Inadequate Control, Renal Failure Acute, Weight Increased
Patient was taking Odrik (View Usage). Patient had the following side effects: diabetes mellitus inadequate control, renal failure acute, weight increased on Jun 09, 2010 from FRANCE Additional patient health information: Female patient , 65 years of age, was diagnosed with hypertension, diabetes mellitus and. Odrik dosage: . During the same period patient was treated with LASIX (View Lasix Review and Lasix Label ), BYETTA (5mcg Twice Daily) (View Byetta Review and Byetta Label ), CACIT (View Cacit Review and Cacit Label ), TEMERIT (View Temerit Review and Temerit Label ), LOXEN (View Loxen Review and Loxen Label ), CRESTOR (View Crestor Review and Crestor Label ), PREVISCAN (View Previscan Review and Previscan Label ), NEURONTIN (View Neurontin Review and Neurontin Label ). Patient was hospitalized.

6725118-X | Agitation, Amnestic Disorder, Amyotrophy, Asthenia, Biliary Dilatation, Bradycardia, Cholelithiasis, Decreased Appetite, Dehydration
Adverse event was reported on May 07, 2010 by a Male patient taking Odrik (View Usage) (Dosage: ) was diagnosed with hypertension, subileus and. Location: , 76 years of age, After Odrik was administered, patient had the following side effects: agitation, amnestic disorder, amyotrophy, asthenia, biliary dilatation, bradycardia, cholelithiasis, decreased appetite, dehydration. During the same period patient was treated with SEROPLEX FILM COATED TABLETS (View Seroplex Film-coated Tablets Review and Seroplex Film-coated Tablets Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), TEMERIT (View Temerit Review and Temerit Label ), TOPALGIC (View Topalgic Review and Topalgic Label ), DIFFU K (View Diffu K Review and Diffu K Label ), ASPEGIC 1000 (View Aspegic 1000 Review and Aspegic 1000 Label ), CRESTOR (View Crestor Review and Crestor Label ), FORLAX (View Forlax Review and Forlax Label ). Patient was hospitalized.

6709155-7 | Bradycardia, Fall, Humerus Fracture, Orthostatic Hypotension
on Apr 29, 2010 Male patient from , 76 years of age, was diagnosed with hypertension and was treated with Odrik (View Usage). Patient experienced the following unwanted or unexpected effects: bradycardia, fall (What is fall?), humerus fracture, orthostatic hypotension. Odrik dosage: . During the same period patient was treated with ESCITALOPRAM (View Escitalopram Review and Escitalopram Label ), FUROSEMID (View Furosemid Review and Furosemid Label ), TEMERIT (View Temerit Review and Temerit Label ), TOPALGIC PR (View Topalgic Pr Review and Topalgic Pr Label ), DIFFU K (View Diffu K Review and Diffu K Label ), ASPEGIC 1000 (View Aspegic 1000 Review and Aspegic 1000 Label ), CRESTOR (View Crestor Review and Crestor Label ), FORLAX (View Forlax Review and Forlax Label ). Patient was hospitalized.


6639078-3 | Diabetes Mellitus Inadequate Control, Renal Failure Acute, Weight Increased
on Mar 08, 2010 Female patient from FRANCE , 65 years of age, was diagnosed with hypertension, diabetes mellitus and was treated with Odrik (View Usage). Patient had the following side effects: diabetes mellitus inadequate control, renal failure acute, weight increased. Odrik dosage: . During the same period patient was treated with LASILIX (View Lasilix Review and Lasilix Label ), BYETTA (View Byetta Review and Byetta Label ), CACIT (View Cacit Review and Cacit Label ), TEMERIT (View Temerit Review and Temerit Label ), LOXEN (View Loxen Review and Loxen Label ), CRESTOR (View Crestor Review and Crestor Label ), PREVISCAN (View Previscan Review and Previscan Label ), NEURONTIN (View Neurontin Review and Neurontin Label ). Patient was hospitalized.

6182474-1 | Hepatitis Cholestatic, Jaundice, Pruritus
Patient was taking Odrik (View Usage). After Odrik was administered, patient had the following side effects: hepatitis cholestatic, jaundice (What is jaundice?), pruritus on Apr 27, 2009 from FRANCE Additional patient health information: Male patient , 81 years of age, was diagnosed with hypertension, phlebitis, lymphangitis, dyslipidaemia and. Odrik dosage: . During the same period patient was treated with PREVISCAN (View Previscan Review and Previscan Label ), AMOXICILLIN (View Amoxicillin Review and Amoxicillin Label ), PYOSTACINE (View Pyostacine Review and Pyostacine Label ), AMLODIPINE BESYLATE (View Amlodipine Besylate Review and Amlodipine Besylate Label ), EZTEROL (View Ezterol Review and Ezterol Label ), CARDENSIEL (View Cardensiel Review and Cardensiel Label ), PARACETAMOL (View Paracetamol Review and Paracetamol Label ). Patient was hospitalized.

6167386-1 | Hepatitis Cholestatic, Jaundice, Pruritus
Adverse event was reported on Apr 15, 2009 by a Male patient taking Odrik (View Usage) (Dosage: ) was diagnosed with hypertension, phlebitis, lymphangitis, dyslipidaemia and. Location: FRANCE , 81 years of age, Patient experienced the following unwanted or unexpected effects: hepatitis cholestatic, jaundice (What is jaundice?), pruritus. During the same period patient was treated with PREVISCAN (View Previscan Review and Previscan Label ), AMOXICILLIN (View Amoxicillin Review and Amoxicillin Label ), PYOSTACINE (View Pyostacine Review and Pyostacine Label ), AMLODIPINE BESYLATE (View Amlodipine Besylate Review and Amlodipine Besylate Label ), EZTEROL (View Ezterol Review and Ezterol Label ), CARDENSIEL (View Cardensiel Review and Cardensiel Label ), PARACETAMOL (View Paracetamol Review and Paracetamol Label ). Patient was hospitalized.

6159352-7 | Fall, Humerus Fracture, Orthostatic Hypotension
on Apr 14, 2009 Male patient from , 76 years of age, was diagnosed with hypertension and was treated with Odrik (View Usage). Patient had the following side effects: fall (What is fall?), humerus fracture, orthostatic hypotension. Odrik dosage: . During the same period patient was treated with ESCITALOPRAM (View Escitalopram Review and Escitalopram Label ), FUROSEMID (View Furosemid Review and Furosemid Label ), TEMERIT (View Temerit Review and Temerit Label ), TOPALGIC PR (View Topalgic Pr Review and Topalgic Pr Label ), DIFFU K (View Diffu K Review and Diffu K Label ), ASPEGIC 325 (View Aspegic 325 Review and Aspegic 325 Label ), CRESTOR (View Crestor Review and Crestor Label ), FORLAX (View Forlax Review and Forlax Label ). Patient was hospitalized.

6157258-0 | Fall, Humerus Fracture, Orthostatic Hypotension
on Apr 14, 2009 Male patient from , 76 years of age, was diagnosed with hypertension and was treated with Odrik (View Usage). After Odrik was administered, patient had the following side effects: fall (What is fall?), humerus fracture, orthostatic hypotension. Odrik dosage: . During the same period patient was treated with FUROSEMID (View Furosemid Review and Furosemid Label ), TEMERIT (View Temerit Review and Temerit Label ), SEROPLEX (View Seroplex Review and Seroplex Label ), TOPALGIC PR (View Topalgic Pr Review and Topalgic Pr Label ), DIFFU K (View Diffu K Review and Diffu K Label ), ASPEGIC 325 (View Aspegic 325 Review and Aspegic 325 Label ), CRESTOR (View Crestor Review and Crestor Label ), FORLAX (View Forlax Review and Forlax Label ). Patient was hospitalized.

6048685-0 | Fall, Hyperkalaemia, Renal Failure Acute
Patient was taking Odrik (View Usage). Patient experienced the following unwanted or unexpected effects: fall (What is fall?), hyperkalaemia, renal failure acute on Jan 15, 2009 from FRANCE Additional patient health information: Male patient , 74 years of age, was diagnosed with hypertension and. Odrik dosage: . During the same period patient was treated with FUROSEMIDE W/SPIRONOLACTONE (View Furosemide W/spironolactone Review and Furosemide W/spironolactone Label ), LACIDIPINE (View Lacidipine Review and Lacidipine Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), FLUINDIONE (View Fluindione Review and Fluindione Label ), AMIODARONE HCL (View Amiodarone Hcl Review and Amiodarone Hcl Label ), MOLSIDOMINE (View Molsidomine Review and Molsidomine Label ), GLICLAZIDE (View Gliclazide Review and Gliclazide Label ), EXTRACT OF GINKGO BILOBA (View Extract Of Ginkgo Biloba Review and Extract Of Ginkgo Biloba Label ). Patient was hospitalized.

5893771-9 | Back Pain, Haematoma, Purpura, Thrombocytopenia
Adverse event was reported on Sep 17, 2008 by a Male patient taking Odrik (View Usage) (Dosage: ) was diagnosed with back pain (What is back pain?) and. Location: FRANCE , 66 years of age, Patient had the following side effects: back pain (What is back pain?), haematoma, purpura, thrombocytopenia. During the same period patient was treated with ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), FLUINDIONE (View Fluindione Review and Fluindione Label ), PRAVASTATIN (View Pravastatin Review and Pravastatin Label ), ACEBUTOLOL (View Acebutolol Review and Acebutolol Label ). Patient was hospitalized.

5779643-9 | Purpura, Rash Erythematous, Rash Macular, Rash Maculo-papular
on Jun 12, 2008 Female patient from FRANCE , 55 years of age, was treated with Odrik (View Usage). After Odrik was administered, patient had the following side effects: purpura, rash erythematous, rash macular, rash maculo-papular. Odrik dosage: . During the same period patient was treated with DILTIAZEM (View Diltiazem Review and Diltiazem Label ), NICERGOLINE (View Nicergoline Review and Nicergoline Label ), TRIMETAZIDINE (View Trimetazidine Review and Trimetazidine Label ), BETAHISTINE (View Betahistine Review and Betahistine Label ), ESOMEPRAZOLE MAGNESIUM (View Esomeprazole Magnesium Review and Esomeprazole Magnesium Label ). Patient was hospitalized.

5703055-7 | Agranulocytosis, Anaemia, Angina Unstable, Blood Creatinine Increased, Chest Pain, Dyspnoea, Haemorrhage, Histiocytosis Haematophagic, Hypersensitivity
on Apr 03, 2008 Male patient from GERMANY , 73 years of age, was diagnosed with angina pectoris and was treated with Odrik (View Usage). Patient experienced the following unwanted or unexpected effects: agranulocytosis, anaemia, angina unstable, blood creatinine increased, chest pain (What is chest pain?), dyspnoea, haemorrhage, histiocytosis haematophagic, hypersensitivity. Odrik dosage: . During the same period patient was treated with INIPOMP (View Inipomp Review and Inipomp Label ), CLOPIDOGREL BISULFATE (View Clopidogrel Bisulfate Review and Clopidogrel Bisulfate Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), ACETYLSALICYLATE LYSINE (View Acetylsalicylate Lysine Review and Acetylsalicylate Lysine Label ), EPOGEN (View Epogen Review and Epogen Label ). Patient was hospitalized.

5618567-4 | Renal Failure Acute
Patient was taking Odrik (View Usage). Patient had the following side effects: renal failure acute on Feb 01, 2008 from FRANCE Additional patient health information: Male patient , 86 years of age, was diagnosed with diabetic nephropathy, cardiomyopathy (What is cardiomyopathy?), hypertension and. Odrik dosage: . During the same period patient was treated with ERTAPENEM (View Ertapenem Review and Ertapenem Label ), OFLOXACINE (View Ofloxacine Review and Ofloxacine Label ), PRISTINAMYCINE (View Pristinamycine Review and Pristinamycine Label ), VERAMIL, TRANDOLAPRIL (View Veramil, Trandolapril Review and Veramil, Trandolapril Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), REPAGLINIDE (View Repaglinide Review and Repaglinide Label ). Patient was hospitalized.

5602950-7 | Renal Failure Acute
Adverse event was reported on Jan 15, 2008 by a Male patient taking Odrik (View Usage) (Dosage: ) . Location: FRANCE , 86 years of age, After Odrik was administered, patient had the following side effects: renal failure acute. During the same period patient was treated with ERTAPENEM (View Ertapenem Review and Ertapenem Label ), OFLOXACINE (View Ofloxacine Review and Ofloxacine Label ), PRISTINAMYCINE (View Pristinamycine Review and Pristinamycine Label ), VERAMIL, TRANDOLAPRIL (View Veramil, Trandolapril Review and Veramil, Trandolapril Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), REPAGLINIDE (View Repaglinide Review and Repaglinide Label ), CHLORURE DE POTASSIUM (View Chlorure De Potassium Review and Chlorure De Potassium Label ), BISOPROLOL FUMARATE (View Bisoprolol Fumarate Review and Bisoprolol Fumarate Label ). Patient was hospitalized.

5531228-5 | Agranulocytosis, Anaemia, Angina Unstable, Blood Creatinine Increased, Chest Pain, Dyspnoea, Haemorrhage, Hypersensitivity, Leukopenia
on Nov 22, 2007 Male patient from GERMANY , 73 years of age, was diagnosed with angina pectoris and was treated with Odrik (View Usage). Patient experienced the following unwanted or unexpected effects: agranulocytosis, anaemia, angina unstable, blood creatinine increased, chest pain (What is chest pain?), dyspnoea, haemorrhage, hypersensitivity, leukopenia. Odrik dosage: . During the same period patient was treated with INIPOMP (View Inipomp Review and Inipomp Label ), CLOPIDOGREL BISULFATE (View Clopidogrel Bisulfate Review and Clopidogrel Bisulfate Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), ACETYLSALICYLATE LYSINE (View Acetylsalicylate Lysine Review and Acetylsalicylate Lysine Label ). Patient was hospitalized.

5344209-1 | Asthenia, Blood Pressure Increased, Dehydration, Diarrhoea, Dyspepsia, Muscle Spasms, Nausea, Proteinuria, Renal Failure Acute
on May 28, 2007 Female patient from UNITED STATES , weighting 172.0 lb, was diagnosed with hypertension, oedema peripheral and was treated with Odrik (View Usage). Patient had the following side effects: asthenia, blood pressure increased, dehydration, diarrhoea, dyspepsia, muscle spasms, nausea (What is nausea?), proteinuria, renal failure acute. Odrik dosage: . During the same period patient was treated with FUROSEMIDE (View Furosemide Review and Furosemide Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), INSULIN (View Insulin Review and Insulin Label ), INSULIN ASPART (View Insulin Aspart Review and Insulin Aspart Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), CALCIUM CARBONATE (View Calcium Carbonate Review and Calcium Carbonate Label ), ISONIAZID (View Isoniazid Review and Isoniazid Label ). Patient was hospitalized.

5334074-0 | Cardiac Arrest, Dyspepsia, Respiratory Arrest
Patient was taking Odrik (View Usage). After Odrik was administered, patient had the following side effects: cardiac arrest (What is cardiac arrest?), dyspepsia, respiratory arrest on May 17, 2007 from FRANCE Additional patient health information: Female patient , 87 years of age, was diagnosed with cardiac failure, hypertension and. Odrik dosage: . During the same period patient was treated with DIGOXIN (View Digoxin Review and Digoxin Label ), FELODIPINE (View Felodipine Review and Felodipine Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), DILTIAZEM HYDROCHLORIDE (View Diltiazem Hydrochloride Review and Diltiazem Hydrochloride Label ), PREDNISOLONE SODIUM SULFOBENZOATE (View Prednisolone Sodium Sulfobenzoate Review and Prednisolone Sodium Sulfobenzoate Label ).

5329396-3 | Asthenia, Blood Pressure Increased, Dehydration, Diarrhoea, Dyspepsia, Muscle Spasms, Nausea, Proteinuria, Renal Failure Acute
Adverse event was reported on May 10, 2007 by a Female patient taking Odrik (View Usage) (Dosage: ) was diagnosed with hypertension, oedema peripheral and. Location: FRANCE , weighting 172.0 lb, Patient experienced the following unwanted or unexpected effects: asthenia, blood pressure increased, dehydration, diarrhoea, dyspepsia, muscle spasms, nausea (What is nausea?), proteinuria, renal failure acute. During the same period patient was treated with FUROSEMIDE (View Furosemide Review and Furosemide Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), INSULIN (View Insulin Review and Insulin Label ), INSULIN ASPART (View Insulin Aspart Review and Insulin Aspart Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), CALCIUM CARBONATE (View Calcium Carbonate Review and Calcium Carbonate Label ), ISONIAZID (View Isoniazid Review and Isoniazid Label ). Patient was hospitalized.

5321864-3 | Cardiac Arrest, Dyspepsia, Respiratory Arrest
on May 04, 2007 Female patient from FRANCE , 87 years of age, was diagnosed with cardiac failure, hypertension and was treated with Odrik (View Usage). Patient had the following side effects: cardiac arrest (What is cardiac arrest?), dyspepsia, respiratory arrest. Odrik dosage: . During the same period patient was treated with DIGOXIN (View Digoxin Review and Digoxin Label ), FELODIPINE (View Felodipine Review and Felodipine Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), DILTIAZEM HYDROCHLORIDE (View Diltiazem Hydrochloride Review and Diltiazem Hydrochloride Label ), PREDNISOLONE SODIUM SULFOBENZOATE (View Prednisolone Sodium Sulfobenzoate Review and Prednisolone Sodium Sulfobenzoate Label ).

5317360-X | Cardiac Murmur, Erythema, Hyperuricaemia, Pulse Absent, Renal Failure Acute, Skin Discolouration
on Apr 25, 2007 Male patient from FRANCE , 86 years of age, weighting 154.3 lb, was treated with Odrik (View Usage). After Odrik was administered, patient had the following side effects: cardiac murmur, erythema, hyperuricaemia, pulse absent, renal failure acute, skin discolouration. Odrik dosage: . During the same period patient was treated with SPIRONOLACTONE (View Spironolactone Review and Spironolactone Label ), AMIODARONE HCL (View Amiodarone Hcl Review and Amiodarone Hcl Label ), ACENOCOUMAROL (View Acenocoumarol Review and Acenocoumarol Label ), CARVEDILOL (View Carvedilol Review and Carvedilol Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ). Patient was hospitalized.

5305111-4 | Cardiac Murmur, Erythema, Hyperuricaemia, Nail Disorder, Pulse Absent, Renal Failure Acute, Respiratory Rate Increased
Patient was taking Odrik (View Usage). Patient experienced the following unwanted or unexpected effects: cardiac murmur, erythema, hyperuricaemia, nail disorder, pulse absent, renal failure acute, respiratory rate increased on Apr 13, 2007 from FRANCE Additional patient health information: Male patient , 86 years of age, weighting 154.3 lb, . Odrik dosage: . During the same period patient was treated with SPIRONOLACTONE (View Spironolactone Review and Spironolactone Label ), AMIODARONE HCL (View Amiodarone Hcl Review and Amiodarone Hcl Label ), ACENOCOUMAROL (View Acenocoumarol Review and Acenocoumarol Label ), CARVEDILOL (View Carvedilol Review and Carvedilol Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ). Patient was hospitalized.

5303644-8 | Asthenia, Blood Pressure Increased, Dehydration, Diarrhoea, Muscle Spasms, Nausea, Proteinuria, Renal Impairment, Skin Turgor Decreased
Adverse event was reported on Apr 13, 2007 by a Female patient taking Odrik (View Usage) (Dosage: ) was diagnosed with hypertension, oedema peripheral and. Location: FRANCE , weighting 172.0 lb, Patient had the following side effects: asthenia, blood pressure increased, dehydration, diarrhoea, muscle spasms, nausea (What is nausea?), proteinuria, renal impairment, skin turgor decreased. During the same period patient was treated with FUROSEMIDE (View Furosemide Review and Furosemide Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ). Patient was hospitalized.

5303601-1 | Agranulocytosis, Anaemia, Angina Unstable, Blood Creatinine Increased, Chest Pain, Dyspnoea, Haemorrhage, Urine Output Decreased
on Apr 12, 2007 Male patient from GERMANY , 73 years of age, was diagnosed with angina pectoris and was treated with Odrik (View Usage). After Odrik was administered, patient had the following side effects: agranulocytosis, anaemia, angina unstable, blood creatinine increased, chest pain (What is chest pain?), dyspnoea, haemorrhage, urine output decreased. Odrik dosage: . During the same period patient was treated with INIPOMP (View Inipomp Review and Inipomp Label ), CLOPIDOGREL BISULFATE (View Clopidogrel Bisulfate Review and Clopidogrel Bisulfate Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ). Patient was hospitalized.

5302334-5 | Cardiac Arrest, Dyspepsia, Respiratory Arrest
on Apr 12, 2007 Female patient from FRANCE , 87 years of age, was treated with Odrik (View Usage). Patient experienced the following unwanted or unexpected effects: cardiac arrest (What is cardiac arrest?), dyspepsia, respiratory arrest. Odrik dosage: . During the same period patient was treated with DIGOXIN (View Digoxin Review and Digoxin Label ), FELODIPINE (View Felodipine Review and Felodipine Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), DILTIAZEM HYDROCHLORIDE (View Diltiazem Hydrochloride Review and Diltiazem Hydrochloride Label ), PREDNISOLONE SODIUM SULFOBENZOATE (View Prednisolone Sodium Sulfobenzoate Review and Prednisolone Sodium Sulfobenzoate Label ).

5284887-9 | Anuria, Asthenia, Hypotension, Renal Failure Acute
Patient was taking Odrik (View Usage). Patient had the following side effects: anuria, asthenia, hypotension, renal failure acute on Mar 26, 2007 from JAPAN Additional patient health information: Male patient , 75 years of age, was diagnosed with prostatitis and. Odrik dosage: . During the same period patient was treated with FUROSEMIDE (View Furosemide Review and Furosemide Label ), ORUDIS (View Orudis Review and Orudis Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), GLICLAZIDE (View Gliclazide Review and Gliclazide Label ), CLOPIDOGREL (View Clopidogrel Review and Clopidogrel Label ), RABEPRAZOLE SODIUM (View Rabeprazole Sodium Review and Rabeprazole Sodium Label ). Patient was hospitalized.

5259429-4 | Renal Failure Acute
Adverse event was reported on Feb 26, 2007 by a Male patient taking Odrik (View Usage) (Dosage: ) was diagnosed with prostatitis and. Location: FRANCE , 75 years of age, After Odrik was administered, patient had the following side effects: renal failure acute. During the same period patient was treated with FUROSEMIDE (View Furosemide Review and Furosemide Label ), KETOPROFEN (View Ketoprofen Review and Ketoprofen Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), GLICLAZIDE (View Gliclazide Review and Gliclazide Label ), CLOPIDOGREL (View Clopidogrel Review and Clopidogrel Label ), RABEPRAZOLE SODIUM (View Rabeprazole Sodium Review and Rabeprazole Sodium Label ). Patient was hospitalized.

5136602-7 | Anaemia, Dyspnoea Exertional, Melaena, Oedema, Overdose, Pain
on Oct 17, 2006 Male patient from FRANCE , 57 years of age, weighting 136.7 lb, was treated with Odrik (View Usage). Patient experienced the following unwanted or unexpected effects: anaemia, dyspnoea exertional, melaena, oedema, overdose, pain (What is pain?). Odrik dosage: . During the same period patient was treated with AMIODARONE HCL (View Amiodarone Hcl Review and Amiodarone Hcl Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), FLUINDIONE (View Fluindione Review and Fluindione Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), OMEPRAZOLE (20) (View Omeprazole Review and Omeprazole Label ), SULFATE FERROUS B9 (View Sulfate Ferrous B9 Review and Sulfate Ferrous B9 Label ), ZOLPIDEM TARTRATE (View Zolpidem Tartrate Review and Zolpidem Tartrate Label ), INSULIN GLARGINE (View Insulin Glargine Review and Insulin Glargine Label ). Patient was hospitalized.

5136600-3 | Lichenoid Keratosis
on Oct 17, 2006 Female patient from FRANCE , 46 years of age, weighting 141.1 lb, was treated with Odrik (View Usage). Patient had the following side effects: lichenoid keratosis. Odrik dosage: . During the same period patient was treated with ATORVASTATIN CALCIUM (View Atorvastatin Calcium Review and Atorvastatin Calcium Label ). Patient was hospitalized.

5126684-0 | Dermatitis Allergic, Toxic Skin Eruption
Patient was taking Odrik (View Usage). After Odrik was administered, patient had the following side effects: dermatitis allergic, toxic skin eruption on Oct 04, 2006 from FRANCE Additional patient health information: Female patient , 68 years of age, was diagnosed with essential hypertension and. Odrik dosage: . During the same period patient was treated with CELIPROLOL CHLORHYDRATE (View Celiprolol Chlorhydrate Review and Celiprolol Chlorhydrate Label ). Patient was hospitalized.

4843566-X | Blood Creatinine Increased, Renal Artery Stenosis
Adverse event was reported on Nov 24, 2005 by a Female patient taking Odrik (View Usage) (Dosage: ) was diagnosed with cardiac failure and. Location: DENMARK , 91 years of age, Patient experienced the following unwanted or unexpected effects: blood creatinine increased, renal artery stenosis. During the same period patient was treated with FUROSEMIDE (View Furosemide Review and Furosemide Label ), POTASSIUM CHLORIDE (View Potassium Chloride Review and Potassium Chloride Label ), SPIRONOLACTONE (View Spironolactone Review and Spironolactone Label ), METOPROLOL (View Metoprolol Review and Metoprolol Label ), ZARATOR (View Zarator Review and Zarator Label ), FERN MONO RETARD (View Fern Mono Retard Review and Fern Mono Retard Label ).

4790421-X | Back Pain, Candidiasis, Eosinophilic Pneumonia, Interstitial Lung Disease, Lung Disorder, Nasal Polyps, Renal Aneurysm, Renal Failure, Tongue Dry
on Sep 26, 2005 Female patient from FRANCE , 70 years of age, weighting 134.5 lb, was treated with Odrik (View Usage). Patient had the following side effects: back pain (What is back pain?), candidiasis, eosinophilic pneumonia, interstitial lung disease, lung disorder, nasal polyps, renal aneurysm, renal failure, tongue dry. Odrik dosage: . During the same period patient was treated with PROPRANOLOL (View Propranolol Review and Propranolol Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), BISOPROLOL (View Bisoprolol Review and Bisoprolol Label ). Patient was hospitalized.

4729386-5 | Hepatitis Cholestatic, Jaundice
on Jul 20, 2005 Female patient from FRANCE , 84 years of age, was diagnosed with essential hypertension, pneumonia (What is pneumonia?), diabetes mellitus and was treated with Odrik (View Usage). After Odrik was administered, patient had the following side effects: hepatitis cholestatic, jaundice (What is jaundice?). Odrik dosage: . During the same period patient was treated with AMOXICILLIN AND CLAVULANATE POTASSIUM (View Amoxicillin And Clavulanate Potassium Review and Amoxicillin And Clavulanate Potassium Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), GLIMEPIRIDE (View Glimepiride Review and Glimepiride Label ), AMIODARONE (View Amiodarone Review and Amiodarone Label ), ESOMEPRAZOLE (View Esomeprazole Review and Esomeprazole Label ), IRBESARTAN (View Irbesartan Review and Irbesartan Label ), PANTOPRAZOLE (View Pantoprazole Review and Pantoprazole Label ), ATENOLOL (View Atenolol Review and Atenolol Label ). Patient was hospitalized.